Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 09, 2015
The United States Pharmacopeial Convention (USP) has announced that Anthony (Tony) Lakavage, J.D., will become Senior Vice President, Global External Affairs, beginning on September 14.
read more
Wednesday, September 02, 2015
Valeant Pharmaceuticals has announced that its affiliate has entered into a collaboration agreement with AstraZeneca under which Valeant was granted an exclusive license to develop and commercialize brodalumab.
read more
Wednesday, September 02, 2015
AstraZeneca has announced that its global biologics research and development arm, MedImmune, has entered an agreement granting Daiichi Sankyo Company, Ltd. (Daiichi Sankyo) an exclusive license to develop and commercialize FluMist® Quadrivalent in ...
read more
Wednesday, September 02, 2015
Novartis announced that the European Commission has approved Revolade® (eltrombopag) for the treatment of adults with severe aplastic anemia (SAA) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable ...
read more
Wednesday, September 02, 2015
AstraZeneca has announced positive topline results from RECAPTURE 1 and RECAPTURE 2, the pivotal Phase III studies evaluating the antibiotic, CAZ-AVI (ceftazidime-avibactam), as a treatment for adult hospitalized patients with complicated Urinary ...
read more
Wednesday, September 02, 2015
Novartis has entered into a global collaboration with Amgen to commercialize and develop pioneering neuroscience treatments.
read more
Wednesday, September 02, 2015
Bristol-Myers Squibb announced that the FDA has accepted for filing and review the supplemental Biologics License Application (sBLA) for Opdivo for the treatment of previously treated patients with non-squamous (NSQ) non-small cell lung cancer (NSCLC...
read more
MPI Research and Exemplar Genetics today announced the first successful validation of a new genetically engineered miniature pig model, offering an attractive alternative to rodent models, of atherosclerosis. The ExeGen® LDLR miniswine is a pig model...
read more
Wednesday, August 26, 2015
IDT Biologika announces today the acquisition of Gallant Custom Laboratories, based in Ontario, Canada. The transaction is to close August 31, 2015.
read more
Wednesday, August 26, 2015
Laboratory Corporation of America Holdings has announced that Covance Drug Development has received a multi-year award from a leading pharmaceutical company to use Covance’s Xcellerate® platform as an exclusive central monitoring solution for their ...
read more
Wednesday, August 26, 2015
BioPharma Services has announced that its Toronto-based Bioanalytical Laboratory has successfully passed its first inspection by the Brazilian regulatory authority, ANVISA.
read more
Wednesday, August 26, 2015
Amneal has announced the creation of Amneal Biosciences, a wholly-owned subsidiary of Amneal Pharmaceuticals LLC. Amneal Biosciences will focus exclusively on the commercialization of high-barrier-to-entry generic and specialty pharmaceuticals.
read more
Wednesday, August 26, 2015
Alvogen has entered into a definitive agreement with Pfizer under which it will acquire a portfolio of four pharmaceutical products.
read more
Wednesday, August 26, 2015
Recipharm AB has signed an agreement with Israeli biopharmaceutical company RedHill Biopharma Ltd for the manufacturing of RedHill’s leading, late-stage patented drug candidate, RHB-105.
read more
Wednesday, August 19, 2015
The FDA has approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the blockbuster success of impotence drugs for men.
read more